Systemic sclerosis: are anti-nuclear antibodies our guiding stars? | ORKG Ask

We use cookies to provide a better user experience.

Data Protection

Related items

Identification of new autoantibody specificities directed at proteins involved in the transforming growth factor beta pathway in patients with systemic sclerosis.

Bussone, Guillaume
Dib, Hanadi
Tamby, Mathieu
Broussard, Cedric
Federici, Christian
Woimant, Geneviève
Camoin, Luc
Guillevin, Loïc
Mouthon, Luc

May 2011

International audienceABSTRACT: INTRODUCTION: Antinuclear antibodies (ANA), usually detected by indi...

Systemic sclerosis: are anti-nuclear antibodies our guiding stars?

Boonstra, M.

November 2022

In this thesis the role of anti-nuclear antibodies to function as biomarkers in systemic sclerosis h...

Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers

Cavazzana I
Vojinovic T
Airo' P
Fredi M
Ceribelli A
Pedretti E
Lazzaroni MG
Garrafa E
Franceschini F.

January 2022

Disease-specific autoantibodies are considered the most important biomarkers for systemic sclerosis ...

Autoreactive B cell responses targeting nuclear antigens in systemic sclerosis: Implications for disease pathogenesis

Liem, Sophie I. E.
Neppelenbroek, Sam
Fehres, Cynthia M.
Wortel, Corrie
Toes, René E. M.
Huizinga, Tom W. J.
Scherer, Hans U.
de Vries-Bouwstra, Jeska K.

February 2023

A hallmark of disease pathogenesis of systemic sclerosis (SSc) is the presence of autoreactive B cel...

Specific anti-nuclear antibodies in systemic sclerosis patients with and without skin involvement : an extended methodological approach

Van Praet, Jens
Van Steendam, Katleen
Smith, Vanessa
De Bruyne, Georges
Mimori, Tsuneyo
Bonroy, Carolien
Elewaut, Dirk
Deforce, Dieter
De Keyser, Filip

January 2011

Methods. Serum samples from 145 consecutive monocentric SSc patients fulfilling LeRoy and Medgser's ...

Association of anti-topoisomerase I antibodies of the IgM isotype with disease progression in anti-topoisomerase I-positive systemic sclerosis

Boonstra, M.
Bakker, J.A.
Grummels, A.
Ninaber, M.K.
Marsan, N.A.
Wortel, C.M.
Huizinga, T.W.J.
Jordan, S.
Hoffman-Vold, A.M.
Distler, O.
Toes, R.E.M.
Scherer, H.U.
Vries-Bouwstra, J.K. de

September 2020

Objective Anti-topoisomerase I (anti-topo I) autoantibodies in systemic sclerosis (SSc) are associat...

Identification of new autoantibody specificities directed at proteins involved in the transforming growth factor beta pathway in patients with systemic sclerosis.

Bussone, Guillaume
Dib, Hanadi
Tamby, Mathieu
Broussard, Cedric
Federici, Christian
Woimant, Geneviève
Camoin, Luc
Guillevin, Loïc
Mouthon, Luc

May 2011

International audienceABSTRACT: INTRODUCTION: Antinuclear antibodies (ANA), usually detected by indi...

Specific anti-nuclear antibodies in systemic sclerosis patients with and without skin involvement : an extended methodological approach

Van Praet, Jens
Van Steendam, Katleen
Smith, Vanessa
De Bruyne, Georges
Mimori, Tsuneyo
Bonroy, Carolien
Elewaut, Dirk
Deforce, Dieter
De Keyser, Filip

January 2011

Methods. Serum samples from 145 consecutive monocentric SSc patients fulfilling LeRoy and Medgser's ...

Association of anti-topoisomerase I antibodies of the IgM isotype with disease progression in anti-topoisomerase I-positive systemic sclerosis

Boonstra, M.
Bakker, J.A.
Grummels, A.
Ninaber, M.K.
Marsan, N.A.
Wortel, C.M.
Huizinga, T.W.J.
Jordan, S.
Hoffman-Vold, A.M.
Distler, O.
Toes, R.E.M.
Scherer, H.U.
Vries-Bouwstra, J.K. de

September 2020

Objective Anti-topoisomerase I (anti-topo I) autoantibodies in systemic sclerosis (SSc) are associat...

Identification of new autoantibody specificities directed at proteins involved in the transforming growth factor beta pathway in patients with systemic sclerosis.

Bussone, Guillaume
Dib, Hanadi
Tamby, Mathieu
Broussard, Cedric
Federici, Christian
Woimant, Geneviève
Camoin, Luc
Guillevin, Loïc
Mouthon, Luc

May 2011

International audienceABSTRACT: INTRODUCTION: Antinuclear antibodies (ANA), usually detected by indi...